• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 425 filed by Churchill Capital Corp X

    2/9/26 4:30:08 PM ET
    $CCCX
    Blank Checks
    Finance
    Get the next $CCCX alert in real time by email
    425 1 d62107d425.htm 425 425

    Filed by Churchill Capital Corp X pursuant to Rule 425

    under the Securities Act of 1933, as amended,

    and deemed filed pursuant to Rule 14a-12

    under the Securities Exchange Act of 1934, as amended

    Subject Company: Churchill Capital Corp X (File No. 001-42646)

    Set forth below is an article published by Benzinga on February 9, 2026, in which the proposed business combination between Churchill Capital Corp X and ColdQuanta, Inc. (“Infleqtion”) is discussed.

    EXCLUSIVE: Infleqtion Eyes 10x Revenue Jump — Can Quantum Deliver The Cash?

    Surbhi Jain

    February 9, 2026

    Benzinga.com

    Wall Street isn’t debating Infleqtion’s $29 million revenue today — it’s betting on whether management can turn a $300 million pipeline into a roughly ten-fold step change in the business.

    In an exclusive interview with Benzinga, CEO Matt Kinsella framed the next two years as a pivot from pilots to scale, cashing in on momentum that is already visible in the field.

    Infleqtion Revenue Growth And $300M Pipeline

    Infleqtion reported $29 million in trailing twelve-month revenue as of June 30, 2025, plus about $50 million in booked and awarded business, growing at roughly 80% annually.

    But Kinsella made clear that the real story is conversion — “scale what is working today” and turn early deployments into multi-year programs that repeat.

    The prize is the $300 million-plus pipeline. If Infleqtion converts even part of that, the company moves from niche supplier to durable quantum contractor — the kind of step change public investors crave.

    Quantum Sensing Revenue: Tiqker, SqyWire, Exaqt

    Near term, revenue is likely to flow from sensing and timing, not computing, says Kinsella. Products like Tiqker (quantum clock), SqyWire (RF receiver), and Exaqt (inertial sensing) are already deployable, with “strong interest from governments and agencies, especially tied to national security use cases.”

    That matters: this is paid work today, not PowerPoint science.

    Computing remains the long game — a market McKinsey pegs at $130 billion by 2040 — but Infleqtion’s strategy is pragmatic: earn now, build later.


    How Infleqtion’s IPO Will Fund Quantum Scaling

    Kinsella said the first IPO dollars will accelerate R&D and deployment capacity — making systems smaller, cheaper, and easier to roll out so demand converts faster into contracts.

    Investor takeaway: Infleqtion’s test isn’t whether quantum arrives — it’s whether a $29 million base can realistically become a $300 million business in a few years. The 10x question now belongs to execution.

    About Infleqtion

    Infleqtion is a global leader in quantum sensing and quantum computing, powered by neutral atom technology. Infleqtion designs and builds quantum computers, precision sensors, and quantum software for governments, enterprises, and research institutions. Infleqtion’s commercial portfolio includes quantum computers as well as quantum RF systems, quantum clocks, and inertial navigation solutions. Infleqtion is the partner of choice for governments and commercial customers seeking cutting-edge quantum capabilities. Infleqtion announced in September 2025 it plans to go public via a merger with Churchill X (NASDAQ: CCCX). For more information, visit Infleqtion.com or follow Infleqtion on LinkedIn, YouTube, and X.

    About Churchill Capital Corp X

    Churchill Capital Corp X (“Churchill X”) is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It may pursue an initial business combination target in any business or industry.

    Additional Information and Where to Find It

    The proposed transaction will be submitted to shareholders of Churchill X for their consideration. Churchill X has filed a registration statement on Form S-4 with the Securities and Exchange Commission (the “SEC”), which was declared effective by the SEC on January 23, 2026, and which includes a definitive proxy statement/prospectus. The definitive proxy statement/prospectus and other relevant documents have been mailed to Infleqtion stockholders and Churchill X shareholders as of January 13, 2026, the record date established for voting on the proposed transaction, in connection with Churchill X’s solicitation of proxies for the vote by Churchill X’s shareholders in connection with the proposed transaction and other matters described in the Registration Statement, as well as the prospectus relating to the offer of the securities to be issued to Infleqtion stockholders in connection with the completion of the proposed transaction. Before making any voting or investment decision, Churchill X shareholders, Infleqtion stockholders and other interested persons are advised to read the definitive proxy statement/prospectus, as well as other documents filed with the SEC by Churchill X in connection with the proposed transaction, as these documents contain important information about Churchill X, Infleqtion and the proposed transaction. Shareholders may obtain a copy of the definitive proxy statement/prospectus, as well as other documents filed by Churchill X with the SEC, without charge, at the SEC’s website located at www.sec.gov or by directing a written request to Churchill Capital Corp X, 640 Fifth Avenue, 14th Floor, New York, NY 10019.

    Forward-Looking Statements

    This communication includes “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Infleqtion has based these forward-looking statements on current expectations and projections about future events. These statements include: projections of market opportunity and market share; estimates of customer adoption rates and usage patterns; projections regarding Infleqtion’s ability to commercialize new products and technologies; projections of development and commercialization costs and timelines; expectations regarding Infleqtion’s ability to execute its business model and the expected financial benefits of such model; expectations regarding Infleqtion’s ability to attract, retain and expand its customer base; Infleqtion’s deployment of proceeds from


    capital raising transactions; Infleqtion’s expectations concerning relationships with strategic partners, suppliers, governments, state-funded entities, regulatory bodies and other third parties; Infleqtion’s ability to maintain, protect and enhance its intellectual property; future ventures or investments in companies, products, services or technologies; development of favorable regulations affecting Infleqtion’s markets; the potential benefits of the proposed transaction and expectations related to its terms and timing; and the potential for Infleqtion to increase in value.

    These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions, many of which are beyond the control of Infleqtion and Churchill X.

    These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that may cause Infleqtion’s or Churchill X’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such statements. Such risks and uncertainties include: that Infleqtion is pursuing an emerging technology, faces significant technical challenges and may not achieve commercialization or market acceptance; Infleqtion’s historical net losses and limited operating history; Infleqtion’s expectations regarding future financial performance, capital requirements and unit economics; Infleqtion’s use and reporting of business and operational metrics; Infleqtion’s competitive landscape; Infleqtion’s dependence on members of its senior management and its ability to attract and retain qualified personnel; Infleqtion’s concentration of revenue in contracts with government or state-funded entities; the potential need for additional future financing; Infleqtion’s ability to manage growth and expand its operations; potential future acquisitions or investments in companies, products, services or technologies; Infleqtion’s reliance on strategic partners and other third parties; Infleqtion’s ability to maintain, protect and defend its intellectual property rights; risks associated with privacy, data protection or cybersecurity incidents and related regulations; the use, rate of adoption and regulation of artificial intelligence and machine learning; uncertainty or changes with respect to laws and regulations; uncertainty or changes with respect to taxes, trade conditions and the macroeconomic environment; the combined company’s ability to maintain internal control over financial reporting and operate a public company; the possibility that required regulatory approvals for the proposed transaction are delayed or are not obtained, which could adversely affect the combined company or the expected benefits of the proposed transaction; the risk that shareholders of Churchill X could elect to have their shares redeemed, leaving the combined company with insufficient cash to execute its business plans; the occurrence of any event, change or other circumstance that could give rise to the termination of the business combination agreement; the outcome of any legal proceedings or government investigations that may be commenced against Infleqtion or Churchill X; failure to realize the anticipated benefits of the proposed transaction; the ability of Churchill X or the combined company to issue equity or equity-linked securities in connection with the proposed transaction or in the future; and other factors described in Churchill X’s filings with the SEC. Additional information concerning these and other factors that may impact such forward-looking statements can be found in filings and potential filings by Infleqtion, Churchill X or the combined company resulting from the proposed transaction with the SEC, including under the heading “Risk Factors.” If any of these risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. In addition, these statements reflect the expectations, plans and forecasts of Infleqtion’s and Churchill X’s management as of the date of this communication; subsequent events and developments may cause their assessments to change. While Infleqtion and Churchill X may elect to update these forward-looking statements at some point in the future, they specifically disclaim any obligation to do so. Accordingly, undue reliance should not be placed upon these statements.

    In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this communication, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. An investment in Churchill X is not an investment in any of our founders’ or sponsors’ past investments, companies or affiliated funds. The historical results of those investments are not indicative of future performance of Churchill X, which may differ materially from the performance of our founders’ or sponsors’ past investments.


    Participants in the Solicitation

    Churchill X, Infleqtion and certain of their respective directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be participants in the solicitation of proxies from Churchill X’s shareholders in connection with the proposed transaction. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of Churchill X’s shareholders in connection with the proposed transaction is set forth in the definitive proxy statement/prospectus filed by Churchill X with the SEC. You can find more information about Churchill X’s directors and executive officers in Churchill X’s final prospectus related to its initial public offering filed with the SEC on May 15, 2025. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests are included in the definitive proxy statement/prospectus. Shareholders, potential investors and other interested persons should read the definitive proxy statement/prospectus carefully before making any voting or investment decisions. You may obtain free copies of these documents from the sources described above.

    No Offer or Solicitation

    This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This communication is not, and under no circumstances is to be construed as, a prospectus, an advertisement or a public offering of the securities described herein in the United States or any other jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or exemptions therefrom. INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE OFFERING OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

    Get the next $CCCX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CCCX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CCCX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Infleqtion Advances ARPA-E Quantum Computing Grid Optimization Program

    Execution phase advances quantum-enabled approaches designed to improve energy grid efficiency, resilience, and operational scale Infleqtion, a global leader in quantum computing and quantum sensing, today announced it has executed its contract with the U.S. Department of Energy's Advanced Research Projects Agency-Energy (ARPA-E), formally launching development under its $6.2 million Enhancing Neutral-atom Computers for Optimizing Delivery of Energy (ENCODE) project. This program, which includes key collaborations with Argonne National Laboratory, the National Laboratory of the Rockies (NRL), EPRI, and ComEd, is the first quantum project for the department focusing on advancing the applic

    2/9/26 9:00:00 AM ET
    $CCCX
    Blank Checks
    Finance

    Infleqtion and Quantum Corridor Demonstrate GPS-Free Quantum Timing Solution for Critical Network Infrastructure

    Live test between Chicago and Northwest Indiana shows up to 40X improvement over GPS for keeping digital systems synchronized Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, today announced a successful live demonstration with Quantum Corridor showing how critical digital infrastructure can stay precisely synchronized without relying on GPS. Quantum Corridor is a quantum-safe, ultra-fast, and highly secure fiber-optic network in the Midwest enabling next-generation communication. The demonstration was conducted across 21.8 kilometers of live urban fiber between Chicago's ORD10 Data Center (350 Cermak) and the Digital Crossroad Data

    2/6/26 9:00:00 AM ET
    $CCCX
    Blank Checks
    Finance

    Infleqtion Accelerates Quantum for Oncology as Q4Bio Challenge Enters Phase Three

    Backed by Wellcome Leap program funding and selected to advance to final-stage demonstrations, Infleqtion moves forward with quantum-enabled biomarker discovery for precision oncology Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, announced that its quantum software team, together with collaborators at the University of Chicago (UChicago) and Massachusetts Institute of Technology (MIT), has been selected to advance to Phase 3 of the Wellcome Leap Quantum for Bio (Q4Bio) Challenge, a global program focused on demonstrating quantum-enabled solutions for human health. The news comes as Infleqtion prepares to go public through a merger

    2/5/26 9:00:00 AM ET
    $CCCX
    Blank Checks
    Finance

    $CCCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Murphy Stephen Anthony

    3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

    8/11/25 4:43:36 PM ET
    $CCCX
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Lapping Paul

    3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

    8/11/25 4:21:06 PM ET
    $CCCX
    Blank Checks
    Finance

    $CCCX
    SEC Filings

    View All

    SEC Form 425 filed by Churchill Capital Corp X

    425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    2/9/26 4:30:08 PM ET
    $CCCX
    Blank Checks
    Finance

    SEC Form 425 filed by Churchill Capital Corp X

    425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    2/9/26 6:01:01 AM ET
    $CCCX
    Blank Checks
    Finance

    SEC Form 425 filed by Churchill Capital Corp X

    425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    2/3/26 5:01:33 PM ET
    $CCCX
    Blank Checks
    Finance